These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27285580)

  • 21. Prolonged allogeneic islet graft survival by protoporphyrins.
    Pileggi A; Molano RD; Berney T; Ichii H; San Jose S; Zahr E; Poggioli R; Linetsky E; Ricordi C; Inverardi L
    Cell Transplant; 2005; 14(2-3):85-96. PubMed ID: 15881418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.
    Lopez-Talavera JC; Garcia-Ocaña A; Sipula I; Takane KK; Cozar-Castellano I; Stewart AF
    Endocrinology; 2004 Feb; 145(2):467-74. PubMed ID: 14551233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
    Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
    Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
    Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
    Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation.
    Hafiz MM; Faradji RN; Froud T; Pileggi A; Baidal DA; Cure P; Ponte G; Poggioli R; Cornejo A; Messinger S; Ricordi C; Alejandro R
    Transplantation; 2005 Dec; 80(12):1718-28. PubMed ID: 16378067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts.
    Tredget EB; Arefanian H; Gill RG; Rajotte RV; Rayat GR
    Cell Transplant; 2008; 17(6):599-608. PubMed ID: 18819248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions.
    Li X; Meng Q; Zhang L
    J Immunol Res; 2018; 2018():2424586. PubMed ID: 30345316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
    Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
    Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preconditioning regimen with a PKCɛ activator improves islet graft function in a mouse transplant model.
    Hamilton D; Rugg C; Davis N; Kvezereli M; Tafti BA; Busque S; Fontaine M
    Cell Transplant; 2014; 23(7):913-9. PubMed ID: 23562311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach.
    Pileggi A; Cobianchi L; Inverardi L; Ricordi C
    Ann N Y Acad Sci; 2006 Oct; 1079():383-98. PubMed ID: 17130583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin treatment of mice recipients preserves beta-cell function in porcine islet transplantation.
    Pakhomov O; Honiger J; Gouin E; Cariolet R; Reach G; Darquy S
    Cell Transplant; 2002; 11(7):721-8. PubMed ID: 12518899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
    Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
    Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
    Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z
    Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.
    Pawlick R; Gala-Lopez B; Pepper AR; Abualhassan N; Bruni A; Suzuki K; Rayat G; Elliott JF; Shapiro AMJ
    Islets; 2017 Jul; 9(4):e1330742. PubMed ID: 28692319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
    Hyder A; Laue C; Schrezenmeir J
    Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
    Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
    Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
    Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.